<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02659592</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-03-3026-DM-CTIL</org_study_id>
    <nct_id>NCT02659592</nct_id>
  </id_info>
  <brief_title>Transplantation of Frozen Thawed Ovarian Tissue High Reproductive Performance</brief_title>
  <official_title>Transplantation of Frozen Thawed Ovarian Tissue Demonstrates High Reproductive Performance and the Need to Revise Restrictive Criteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Design: prospective cohort study. Setting: Tertiary university-affiliated ART and oncology
      centers. Patients: 20 cancer survivors who underwent ovarian transplantation of frozen-thawed
      ovarian tissue, with the aim to conceive.

      Interventions: Ovarian tissue cryopreservation (OTCP) and transplantation, endocrine
      monitoring, IVF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Main Outcomes expected:

      Endocrine profile IVF results, pregnancy rates following transplantation of ovarian tissue
      live-births rates following transplantation of ovarian tissue cancer disease recurrence
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>menstrual bleeding (yes/no)</measure>
    <time_frame>up to one year</time_frame>
    <description>recurrence of menstrual bleeding- yes or no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of oocytes per IVF cycle</measure>
    <time_frame>through study completion (up to 11 years following transplantation)</time_frame>
    <description>number of aspirated oovytes per one IVF cycle performed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pregnancies</measure>
    <time_frame>through study completion (up to 11 years following transplantation)</time_frame>
    <description>spontaneous or post IVF pregnancy rates (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>live births</measure>
    <time_frame>through study completion (up to 11 years following transplantation)</time_frame>
    <description>live birth rates (%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>disease reccurence</measure>
    <time_frame>through study completion (7 months to 141 months following transplantation)</time_frame>
    <description>incidence of cancer disease recurrence</description>
  </secondary_outcome>
  <other_outcome>
    <measure>FSH levels (miU/ml)</measure>
    <time_frame>up to one year</time_frame>
    <description>as part of the endocrine profile</description>
  </other_outcome>
  <other_outcome>
    <measure>E2 (pmol/ml),</measure>
    <time_frame>up to one year</time_frame>
    <description>as part of the endocrine profile</description>
  </other_outcome>
  <other_outcome>
    <measure>number of embryos per IVF cycle</measure>
    <time_frame>through study completion (up to 11 years following transplantation)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>IVF cycles pregnancy rates (%)</measure>
    <time_frame>through study completion (up to 11 years following transplantation)</time_frame>
    <description>number of pregnancies obtained via IVF devided by number of IVF cycles</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Reproductive Performance Following Ovarian Transplantation</condition>
  <arm_group>
    <arm_group_label>infertile cancer survivors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infertile cancer survivors who seek to conceive and had frozen ovarian tissue when diagnosed years before</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transplantation of ovarian tissue</intervention_name>
    <description>operation(mini laparotomy) for transplantation of frozen- thawed ovarian tissue</description>
    <arm_group_label>infertile cancer survivors</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: infertile patients who stored ovarian tissue to preserve fertility
        prior to potentially sterilizing cancer treatments

        Exclusion Criteria:

          -  active disease, fertile patients post cancer treatment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2016</study_first_submitted>
  <study_first_submitted_qc>January 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2016</study_first_posted>
  <last_update_submitted>January 19, 2016</last_update_submitted>
  <last_update_submitted_qc>January 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Prof. Dror Meirow</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>fertility preservation</keyword>
  <keyword>ovarian tissue transplantation</keyword>
  <keyword>ovarian endocrine function</keyword>
  <keyword>assisted reproductive technology</keyword>
  <keyword>pregnancy and live birth</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

